Stay updated with breaking news from John Sims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
An Alzheimer’s drug that attacks the protein amyloid does not work as well in people with more advanced disease
Eli Lilly's experimental Alzheimer's drug donanemab can modestly slow the worsening of the disease by about four to seven months, according to researchers.
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
